Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Insulin Resistance × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 2 Osteosarcoma 1 Neoplasms by Site 1 Neoplasms 1 Multiple Myeloma 1 Insulin Resistance 1 Fatigue 1 Breast Diseases 1

Interventions

Zoledronic Acid 1 Radiotherapy 1 Preoperative Exercise 1 Observation 1 Metformin 1 Hypoglycemic Agents 1 Diet, Carbohydrate-Restricted 1 Biguanides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Austin Health

Phase 2/3 Completed

Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡